Shopping Cart 0
Cart Subtotal
USD 0

Global Biologics and Biosimilars Market Analysis 2013-2018 and Forecast 2019-2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2980

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5960

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 5960
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Snapshot

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original innovator products, and can be manufactured when the original product's patent expires.

The global Biologics and Biosimilars market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Biologics and Biosimilars by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Antibody

Hormone

Growth Factors

Others

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Tumor

Diabetes

Cardiovascular

Hemophilia

Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Table Of Content

Scope

Table of Contents

1 Industry Overview

1.1 Biologics and Biosimilars Industry

1.1.1 Overview

1.1.2 Development of Biologics and Biosimilars

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Biologics and Biosimilars Market by Type

3.1 By Type

3.1.1 Antibody

3.1.2 Hormone

3.1.3 Growth Factors

3.1.4 Others

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Biologics and Biosimilars Roche (Company Profile, Sales Data etc.)

4.2 Amgen (Company Profile, Sales Data etc.)

4.3 AbbVie (Company Profile, Sales Data etc.)

4.4 Sanofi-Aventis (Company Profile, Sales Data etc.)

4.5 Johnson & Johnson (Company Profile, Sales Data etc.)

4.6 Pfizer (Company Profile, Sales Data etc.)

4.7 Novo Nordisk (Company Profile, Sales Data etc.)

4.8 Eli Lilly (Company Profile, Sales Data etc.)

4.9 Novartis (Company Profile, Sales Data etc.)

4.10 Merck (Company Profile, Sales Data etc.)

4.11 3sbio (Company Profile, Sales Data etc.)

4.12 Changchun High Tech (Company Profile, Sales Data etc.)

4.13 CP Guojian (Company Profile, Sales Data etc.)

4.14 Biotech (Company Profile, Sales Data etc.)

4.15 Gelgen (Company Profile, Sales Data etc.)

4.16 Innovent (Company Profile, Sales Data etc.)

4.17 Dong Bao (Company Profile, Sales Data etc.)

4.18 Ganlee (Company Profile, Sales Data etc.)

4.19 United Laboratories (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Tumor

6.1.2 Demand in Diabetes

6.1.3 Demand in Cardiovascular

6.1.4 Demand in Hemophilia

6.1.5 Demand in Others

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Biologics and Biosimilars Market Growth 2013-2018, by Type, in USD Million

Figure North America Biologics and Biosimilars Market Concentration, in 2018

Figure Europe Biologics and Biosimilars Market Market Concentration, in 2018

Figure Asia-Pacific Biologics and Biosimilars MMarket Concentration, in 2018

Figure South America Biologics and Biosimilars Market Concentration, in 2018

Figure Middle East & Africa Biologics and Biosimilars Market Concentration, in 2018

Figure Biologics and Biosimilars Demand in Tumor, 2013-2018, in USD Million

Figure Biologics and Biosimilars Demand in Diabetes, 2013-2018, in USD Million

Figure Biologics and Biosimilars Demand in Cardiovascular, 2013-2018, in USD Million

Figure Biologics and Biosimilars Demand in Hemophilia, 2013-2018, in USD Million

Figure Biologics and Biosimilars Demand in Others, 2013-2018, in USD Million

Figure North America Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure Europe Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure South America Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Biologics and Biosimilars

Table Application Segment of Biologics and Biosimilars

Table Global Biologics and Biosimilars Market 2013-2024, by Application, in USD Million

Table Major Company List of Antibody

Table Major Company List of Hormone

Table Major Company List of Growth Factors

Table Major Company List of Others

Table Global Biologics and Biosimilars Market 2013-2018, by Type, in USD Million

Table Global Biologics and Biosimilars Market Forecast 2019-2024, by Type, in USD Million

Table Roche Overview List

Table Biologics and Biosimilars Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Amgen Overview List

Table Biologics and Biosimilars Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AbbVie Overview List

Table Biologics and Biosimilars Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi-Aventis Overview List

Table Biologics and Biosimilars Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Biologics and Biosimilars Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Biologics and Biosimilars Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novo Nordisk Overview List

Table Biologics and Biosimilars Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Biologics and Biosimilars Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Biologics and Biosimilars Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck Overview List

Table Biologics and Biosimilars Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 3sbio Overview List

Table Biologics and Biosimilars Business Operation of 3sbio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Changchun High Tech Overview List

Table Biologics and Biosimilars Business Operation of Changchun High Tech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CP Guojian Overview List

Table Biologics and Biosimilars Business Operation of CP Guojian (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Biotech Overview List

Table Biologics and Biosimilars Business Operation of Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Gelgen Overview List

Table Biologics and Biosimilars Business Operation of Gelgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Innovent Overview List

Table Biologics and Biosimilars Business Operation of Innovent (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Dong Bao Overview List

Table Biologics and Biosimilars Business Operation of Dong Bao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ganlee Overview List

Table Biologics and Biosimilars Business Operation of Ganlee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table United Laboratories Overview List

Table Biologics and Biosimilars Business Operation of United Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Biologics and Biosimilars Sales Revenue 2013-2018, by Company, in USD Million

Table Global Biologics and Biosimilars Sales Revenue Share, by Company, in USD Million

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Biologics and Biosimilars Demand Forecast 2019-2024, by Application, in USD Million

Table Biologics and Biosimilars Production 2013-2018, by Region, in USD Million

Table Global Biologics and Biosimilars Market 2013-2018, by Region, in USD Million

Table Global Biologics and Biosimilars Market Share 2013-2018, by Region, in USD Million

Table North America Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million

Table Europe Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million

Table South America Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million

Table Biologics and Biosimilars Market Forecast 2019-2024, by Region, in USD Million

Table Price Factors List

Licence Rights

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Snapshot

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original innovator products, and can be manufactured when the original product's patent expires.

The global Biologics and Biosimilars market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Biologics and Biosimilars by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Antibody

Hormone

Growth Factors

Others

Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):

Tumor

Diabetes

Cardiovascular

Hemophilia

Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):

North America (U.S., Canada, Mexico)

Europe (Germany, U.K., France, Italy, Russia, Spain etc.)

Asia-Pacific (China, India, Japan, Southeast Asia etc.)

South America (Brazil, Argentina etc.)

Middle East & Africa (Saudi Arabia, South Africa etc.)

READ MORE

Scope

Table of Contents

1 Industry Overview

1.1 Biologics and Biosimilars Industry

1.1.1 Overview

1.1.2 Development of Biologics and Biosimilars

1.2 Market Segment

1.2.1 Upstream

1.2.2 Downstream

1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

2.1 Policy

2.2 Economics

2.3 Sociology

2.4 Technology

3 Biologics and Biosimilars Market by Type

3.1 By Type

3.1.1 Antibody

3.1.2 Hormone

3.1.3 Growth Factors

3.1.4 Others

3.2 Market Size

3.3 Market Forecast

4 Major Companies List

4.Biologics and Biosimilars Roche (Company Profile, Sales Data etc.)

4.2 Amgen (Company Profile, Sales Data etc.)

4.3 AbbVie (Company Profile, Sales Data etc.)

4.4 Sanofi-Aventis (Company Profile, Sales Data etc.)

4.5 Johnson & Johnson (Company Profile, Sales Data etc.)

4.6 Pfizer (Company Profile, Sales Data etc.)

4.7 Novo Nordisk (Company Profile, Sales Data etc.)

4.8 Eli Lilly (Company Profile, Sales Data etc.)

4.9 Novartis (Company Profile, Sales Data etc.)

4.10 Merck (Company Profile, Sales Data etc.)

4.11 3sbio (Company Profile, Sales Data etc.)

4.12 Changchun High Tech (Company Profile, Sales Data etc.)

4.13 CP Guojian (Company Profile, Sales Data etc.)

4.14 Biotech (Company Profile, Sales Data etc.)

4.15 Gelgen (Company Profile, Sales Data etc.)

4.16 Innovent (Company Profile, Sales Data etc.)

4.17 Dong Bao (Company Profile, Sales Data etc.)

4.18 Ganlee (Company Profile, Sales Data etc.)

4.19 United Laboratories (Company Profile, Sales Data etc.)

5 Market Competition

5.1 Company Competition

5.2 Regional Market by Company

6 Demand by End Market

6.1 Demand Situation

6.1.1 Demand in Tumor

6.1.2 Demand in Diabetes

6.1.3 Demand in Cardiovascular

6.1.4 Demand in Hemophilia

6.1.5 Demand in Others

6.2 Regional Demand Comparison

6.3 Demand Forecast

7 Region Operation

7.1 Regional Production

7.2 Regional Market

7.3 by Region

7.3.1 North America

7.3.1.1 Overview

7.3.1.2 by Country (U.S., Canada, Mexico)

7.3.2 Europe

7.3.2.1 Overview

7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)

7.3.3 Asia-Pacific

7.3.3.1 Overview

7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)

7.3.4 South America

7.3.4.1 Overview

7.3.4.2 by Country (Brazil, Argentina etc.)

7.3.5 Middle East & Africa

7.3.5.1 Overview

7.3.5.2 by Country (Saudi Arabia, South Africa etc.)

7.4 Regional Import & Export

7.5 Regional Forecast

8 Marketing & Price

8.1 Price and Margin

8.1.1 Price Trends

8.1.2 Factors of Price Change

8.1.3 Manufacturers Gross Margin Analysis

8.2 Marketing Channel

9 Research Conclusion


List Of Figure

Figure Global Biologics and Biosimilars Market Growth 2013-2018, by Type, in USD Million

Figure North America Biologics and Biosimilars Market Concentration, in 2018

Figure Europe Biologics and Biosimilars Market Market Concentration, in 2018

Figure Asia-Pacific Biologics and Biosimilars MMarket Concentration, in 2018

Figure South America Biologics and Biosimilars Market Concentration, in 2018

Figure Middle East & Africa Biologics and Biosimilars Market Concentration, in 2018

Figure Biologics and Biosimilars Demand in Tumor, 2013-2018, in USD Million

Figure Biologics and Biosimilars Demand in Diabetes, 2013-2018, in USD Million

Figure Biologics and Biosimilars Demand in Cardiovascular, 2013-2018, in USD Million

Figure Biologics and Biosimilars Demand in Hemophilia, 2013-2018, in USD Million

Figure Biologics and Biosimilars Demand in Others, 2013-2018, in USD Million

Figure North America Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure Europe Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure South America Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Biologics and Biosimilars Market Size and Growth 2013-2018, in USD Million

Figure Marketing Channels Overview


List Of Table

Table Upstream Segment of Biologics and Biosimilars

Table Application Segment of Biologics and Biosimilars

Table Global Biologics and Biosimilars Market 2013-2024, by Application, in USD Million

Table Major Company List of Antibody

Table Major Company List of Hormone

Table Major Company List of Growth Factors

Table Major Company List of Others

Table Global Biologics and Biosimilars Market 2013-2018, by Type, in USD Million

Table Global Biologics and Biosimilars Market Forecast 2019-2024, by Type, in USD Million

Table Roche Overview List

Table Biologics and Biosimilars Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Amgen Overview List

Table Biologics and Biosimilars Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AbbVie Overview List

Table Biologics and Biosimilars Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi-Aventis Overview List

Table Biologics and Biosimilars Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Johnson & Johnson Overview List

Table Biologics and Biosimilars Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table Biologics and Biosimilars Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novo Nordisk Overview List

Table Biologics and Biosimilars Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table Biologics and Biosimilars Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Biologics and Biosimilars Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merck Overview List

Table Biologics and Biosimilars Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 3sbio Overview List

Table Biologics and Biosimilars Business Operation of 3sbio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Changchun High Tech Overview List

Table Biologics and Biosimilars Business Operation of Changchun High Tech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table CP Guojian Overview List

Table Biologics and Biosimilars Business Operation of CP Guojian (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Biotech Overview List

Table Biologics and Biosimilars Business Operation of Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Gelgen Overview List

Table Biologics and Biosimilars Business Operation of Gelgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Innovent Overview List

Table Biologics and Biosimilars Business Operation of Innovent (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Dong Bao Overview List

Table Biologics and Biosimilars Business Operation of Dong Bao (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Ganlee Overview List

Table Biologics and Biosimilars Business Operation of Ganlee (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table United Laboratories Overview List

Table Biologics and Biosimilars Business Operation of United Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Biologics and Biosimilars Sales Revenue 2013-2018, by Company, in USD Million

Table Global Biologics and Biosimilars Sales Revenue Share, by Company, in USD Million

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Biologics and Biosimilars Demand Forecast 2019-2024, by Application, in USD Million

Table Biologics and Biosimilars Production 2013-2018, by Region, in USD Million

Table Global Biologics and Biosimilars Market 2013-2018, by Region, in USD Million

Table Global Biologics and Biosimilars Market Share 2013-2018, by Region, in USD Million

Table North America Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million

Table Europe Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million

Table South America Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Biologics and Biosimilars Market Size 2013-2018, by Country, in USD Million

Table Biologics and Biosimilars Market Forecast 2019-2024, by Region, in USD Million

Table Price Factors List

"Single User License
allow one user to read, print, and edit the report

Enterprise License
allow all employees within client's company, to read, print, edit the report"

To know more information on Purchase by Section, please send a mail to support@kenresearch.com
chat_bubbleLet's Chat